Global Suraputide Market Growth 2026-2032
The global Suraputide market size is predicted to grow from US$ 17.75 million in 2025 to US$ 542 million in 2032; it is expected to grow at a CAGR of 17.8% from 2026 to 2032.
Suraputide is an innovative long?acting GLP?1 receptor agonist independently developed in China. By activating the GLP?1 receptor, it promotes insulin secretion and inhibits glucagon release in a glucose?dependent manner, thereby effectively lowering blood glucose. It also exerts effects of delaying gastric emptying, suppressing appetite, reducing body weight, and providing potential cardiorenal protection. The drug achieves long?acting activity through Fc fusion protein technology and is administered by subcutaneous injection once weekly. It is mainly indicated for glycemic control in adults with type 2 diabetes mellitus. As the first domestically invented long?acting GLP?1 analogue approved in China, it features favorable safety, convenient administration and high compliance, and offers important clinical value for potential expansion into indications such as obesity and metabolic syndrome.In 2025, global Suraputide production reached approximately 300,000 vials.
As the first domestically developed long?acting GLP?1 receptor agonist in China, suraputide operates in a rapidly expanding and highly competitive market for metabolic disease drugs. With the convenience of once?weekly administration, favorable safety profile, and locally tailored pricing advantages, the product has quickly entered the field of type 2 diabetes treatment since its launch. Its inclusion in medical insurance has further boosted both market coverage and patient accessibility. Although the current market is dominated by international pharmaceutical giants, accompanied by intensified competition among similar products and pressure on pricing, suraputide has established distinctive competitiveness in the two core sectors of diabetes and weight management by relying on its differentiated Fc fusion protein technology, as well as local R&D and commercialization strengths. In the long run, with the gradual expansion of indications to include obesity and metabolic syndrome, the advancement of overseas market deployment, and the rising penetration rate and consumption upgrade of GLP?1 drugs in China, the product is expected to continuously expand its market share in the trillion?level market and become an important benchmark for domestic innovative drugs in the field of metabolic diseases.
LP Information, Inc. (LPI) ' newest research report, the ?Suraputide Industry Forecast? looks at past sales and reviews total world Suraputide sales in 2025, providing a comprehensive analysis by region and market sector of projected Suraputide sales for 2026 through 2032. With Suraputide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Suraputide industry.
This Insight Report provides a comprehensive analysis of the global Suraputide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Suraputide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Suraputide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Suraputide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Suraputide.
This report presents a comprehensive overview, market shares, and growth opportunities of Suraputide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Suraputide market?
What factors are driving Suraputide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Suraputide market opportunities vary by end market size?
How does Suraputide break out by Type, by Application?
Suraputide is an innovative long?acting GLP?1 receptor agonist independently developed in China. By activating the GLP?1 receptor, it promotes insulin secretion and inhibits glucagon release in a glucose?dependent manner, thereby effectively lowering blood glucose. It also exerts effects of delaying gastric emptying, suppressing appetite, reducing body weight, and providing potential cardiorenal protection. The drug achieves long?acting activity through Fc fusion protein technology and is administered by subcutaneous injection once weekly. It is mainly indicated for glycemic control in adults with type 2 diabetes mellitus. As the first domestically invented long?acting GLP?1 analogue approved in China, it features favorable safety, convenient administration and high compliance, and offers important clinical value for potential expansion into indications such as obesity and metabolic syndrome.In 2025, global Suraputide production reached approximately 300,000 vials.
As the first domestically developed long?acting GLP?1 receptor agonist in China, suraputide operates in a rapidly expanding and highly competitive market for metabolic disease drugs. With the convenience of once?weekly administration, favorable safety profile, and locally tailored pricing advantages, the product has quickly entered the field of type 2 diabetes treatment since its launch. Its inclusion in medical insurance has further boosted both market coverage and patient accessibility. Although the current market is dominated by international pharmaceutical giants, accompanied by intensified competition among similar products and pressure on pricing, suraputide has established distinctive competitiveness in the two core sectors of diabetes and weight management by relying on its differentiated Fc fusion protein technology, as well as local R&D and commercialization strengths. In the long run, with the gradual expansion of indications to include obesity and metabolic syndrome, the advancement of overseas market deployment, and the rising penetration rate and consumption upgrade of GLP?1 drugs in China, the product is expected to continuously expand its market share in the trillion?level market and become an important benchmark for domestic innovative drugs in the field of metabolic diseases.
LP Information, Inc. (LPI) ' newest research report, the ?Suraputide Industry Forecast? looks at past sales and reviews total world Suraputide sales in 2025, providing a comprehensive analysis by region and market sector of projected Suraputide sales for 2026 through 2032. With Suraputide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Suraputide industry.
This Insight Report provides a comprehensive analysis of the global Suraputide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Suraputide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Suraputide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Suraputide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Suraputide.
This report presents a comprehensive overview, market shares, and growth opportunities of Suraputide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1 mg (0.5 mL) / pen
- 3 mg (0.5 mL) / pen
- Combination of Supaglutide and Metformin
- Combination of Supaglutide and DPP-4 inhibitors
- Hospital
- Retail
- Online
- Type 2 Diabetes Mellitus
- Obesity
- Metabolic Syndrome
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Guangzhou InnoGen Pharmaceuticals
What is the 10-year outlook for the global Suraputide market?
What factors are driving Suraputide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Suraputide market opportunities vary by end market size?
How does Suraputide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Suraputide Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Suraputide by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Suraputide by Country/Region, 2021, 2025 & 2032
2.2 Suraputide Segment by Type
2.2.1 1 mg (0.5 mL) / pen
2.2.2 3 mg (0.5 mL) / pen
2.2.3 Suraputide Sales by Type
2.2.3.1 Global Suraputide Sales Market Share by Type (2021-2026)
2.2.3.2 Global Suraputide Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Suraputide Sale Price by Type (2021-2026)
2.3 Suraputide Segment by Combination Therapy
2.3.1 Combination of Supaglutide and Metformin
2.3.2 Combination of Supaglutide and DPP-4 inhibitors
2.3.3 Suraputide Sales by Combination Therapy
2.3.3.1 Global Suraputide Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Suraputide Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Suraputide Sale Price by Combination Therapy (2021-2026)
2.4 Suraputide Segment by Sales Channel
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Suraputide Sales by Sales Channel
2.4.4.1 Global Suraputide Sales Market Share by Sales Channel (2021-2026)
2.4.4.2 Global Suraputide Revenue and Market Share by Sales Channel (2021-2026)
2.4.4.3 Global Suraputide Sale Price by Sales Channel (2021-2026)
2.5 Suraputide Segment by Application
2.5.1 Type 2 Diabetes Mellitus
2.5.2 Obesity
2.5.3 Metabolic Syndrome
2.5.4 Others
2.5.5 Suraputide Sales by Application
2.5.5.1 Global Suraputide Sale Market Share by Application (2021-2026)
2.5.5.2 Global Suraputide Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Suraputide Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Suraputide Breakdown Data by Company
3.1.1 Global Suraputide Annual Sales by Company (2021-2026)
3.1.2 Global Suraputide Sales Market Share by Company (2021-2026)
3.2 Global Suraputide Annual Revenue by Company (2021-2026)
3.2.1 Global Suraputide Revenue by Company (2021-2026)
3.2.2 Global Suraputide Revenue Market Share by Company (2021-2026)
3.3 Global Suraputide Sale Price by Company
3.4 Key Manufacturers Suraputide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Suraputide Product Location Distribution
3.4.2 Players Suraputide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SURAPUTIDE BY GEOGRAPHIC REGION
4.1 World Historic Suraputide Market Size by Geographic Region (2021-2026)
4.1.1 Global Suraputide Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Suraputide Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Suraputide Market Size by Country/Region (2021-2026)
4.2.1 Global Suraputide Annual Sales by Country/Region (2021-2026)
4.2.2 Global Suraputide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Suraputide Sales Growth
4.4 APAC Suraputide Sales Growth
4.5 Europe Suraputide Sales Growth
4.6 Middle East & Africa Suraputide Sales Growth
5 AMERICAS
5.1 Americas Suraputide Sales by Country
5.1.1 Americas Suraputide Sales by Country (2021-2026)
5.1.2 Americas Suraputide Revenue by Country (2021-2026)
5.2 Americas Suraputide Sales by Type (2021-2026)
5.3 Americas Suraputide Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Suraputide Sales by Region
6.1.1 APAC Suraputide Sales by Region (2021-2026)
6.1.2 APAC Suraputide Revenue by Region (2021-2026)
6.2 APAC Suraputide Sales by Type (2021-2026)
6.3 APAC Suraputide Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Suraputide by Country
7.1.1 Europe Suraputide Sales by Country (2021-2026)
7.1.2 Europe Suraputide Revenue by Country (2021-2026)
7.2 Europe Suraputide Sales by Type (2021-2026)
7.3 Europe Suraputide Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Suraputide by Country
8.1.1 Middle East & Africa Suraputide Sales by Country (2021-2026)
8.1.2 Middle East & Africa Suraputide Revenue by Country (2021-2026)
8.2 Middle East & Africa Suraputide Sales by Type (2021-2026)
8.3 Middle East & Africa Suraputide Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Suraputide
10.3 Manufacturing Process Analysis of Suraputide
10.4 Industry Chain Structure of Suraputide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Suraputide Distributors
11.3 Suraputide Customer
12 WORLD FORECAST REVIEW FOR SURAPUTIDE BY GEOGRAPHIC REGION
12.1 Global Suraputide Market Size Forecast by Region
12.1.1 Global Suraputide Forecast by Region (2027-2032)
12.1.2 Global Suraputide Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Suraputide Forecast by Type (2027-2032)
12.7 Global Suraputide Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Guangzhou InnoGen Pharmaceuticals
13.1.1 Guangzhou InnoGen Pharmaceuticals Company Information
13.1.2 Guangzhou InnoGen Pharmaceuticals Suraputide Product Portfolios and Specifications
13.1.3 Guangzhou InnoGen Pharmaceuticals Suraputide Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Guangzhou InnoGen Pharmaceuticals Main Business Overview
13.1.5 Guangzhou InnoGen Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Suraputide Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Suraputide by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Suraputide by Country/Region, 2021, 2025 & 2032
2.2 Suraputide Segment by Type
2.2.1 1 mg (0.5 mL) / pen
2.2.2 3 mg (0.5 mL) / pen
2.2.3 Suraputide Sales by Type
2.2.3.1 Global Suraputide Sales Market Share by Type (2021-2026)
2.2.3.2 Global Suraputide Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Suraputide Sale Price by Type (2021-2026)
2.3 Suraputide Segment by Combination Therapy
2.3.1 Combination of Supaglutide and Metformin
2.3.2 Combination of Supaglutide and DPP-4 inhibitors
2.3.3 Suraputide Sales by Combination Therapy
2.3.3.1 Global Suraputide Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Suraputide Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Suraputide Sale Price by Combination Therapy (2021-2026)
2.4 Suraputide Segment by Sales Channel
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Suraputide Sales by Sales Channel
2.4.4.1 Global Suraputide Sales Market Share by Sales Channel (2021-2026)
2.4.4.2 Global Suraputide Revenue and Market Share by Sales Channel (2021-2026)
2.4.4.3 Global Suraputide Sale Price by Sales Channel (2021-2026)
2.5 Suraputide Segment by Application
2.5.1 Type 2 Diabetes Mellitus
2.5.2 Obesity
2.5.3 Metabolic Syndrome
2.5.4 Others
2.5.5 Suraputide Sales by Application
2.5.5.1 Global Suraputide Sale Market Share by Application (2021-2026)
2.5.5.2 Global Suraputide Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Suraputide Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Suraputide Breakdown Data by Company
3.1.1 Global Suraputide Annual Sales by Company (2021-2026)
3.1.2 Global Suraputide Sales Market Share by Company (2021-2026)
3.2 Global Suraputide Annual Revenue by Company (2021-2026)
3.2.1 Global Suraputide Revenue by Company (2021-2026)
3.2.2 Global Suraputide Revenue Market Share by Company (2021-2026)
3.3 Global Suraputide Sale Price by Company
3.4 Key Manufacturers Suraputide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Suraputide Product Location Distribution
3.4.2 Players Suraputide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SURAPUTIDE BY GEOGRAPHIC REGION
4.1 World Historic Suraputide Market Size by Geographic Region (2021-2026)
4.1.1 Global Suraputide Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Suraputide Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Suraputide Market Size by Country/Region (2021-2026)
4.2.1 Global Suraputide Annual Sales by Country/Region (2021-2026)
4.2.2 Global Suraputide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Suraputide Sales Growth
4.4 APAC Suraputide Sales Growth
4.5 Europe Suraputide Sales Growth
4.6 Middle East & Africa Suraputide Sales Growth
5 AMERICAS
5.1 Americas Suraputide Sales by Country
5.1.1 Americas Suraputide Sales by Country (2021-2026)
5.1.2 Americas Suraputide Revenue by Country (2021-2026)
5.2 Americas Suraputide Sales by Type (2021-2026)
5.3 Americas Suraputide Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Suraputide Sales by Region
6.1.1 APAC Suraputide Sales by Region (2021-2026)
6.1.2 APAC Suraputide Revenue by Region (2021-2026)
6.2 APAC Suraputide Sales by Type (2021-2026)
6.3 APAC Suraputide Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Suraputide by Country
7.1.1 Europe Suraputide Sales by Country (2021-2026)
7.1.2 Europe Suraputide Revenue by Country (2021-2026)
7.2 Europe Suraputide Sales by Type (2021-2026)
7.3 Europe Suraputide Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Suraputide by Country
8.1.1 Middle East & Africa Suraputide Sales by Country (2021-2026)
8.1.2 Middle East & Africa Suraputide Revenue by Country (2021-2026)
8.2 Middle East & Africa Suraputide Sales by Type (2021-2026)
8.3 Middle East & Africa Suraputide Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Suraputide
10.3 Manufacturing Process Analysis of Suraputide
10.4 Industry Chain Structure of Suraputide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Suraputide Distributors
11.3 Suraputide Customer
12 WORLD FORECAST REVIEW FOR SURAPUTIDE BY GEOGRAPHIC REGION
12.1 Global Suraputide Market Size Forecast by Region
12.1.1 Global Suraputide Forecast by Region (2027-2032)
12.1.2 Global Suraputide Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Suraputide Forecast by Type (2027-2032)
12.7 Global Suraputide Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Guangzhou InnoGen Pharmaceuticals
13.1.1 Guangzhou InnoGen Pharmaceuticals Company Information
13.1.2 Guangzhou InnoGen Pharmaceuticals Suraputide Product Portfolios and Specifications
13.1.3 Guangzhou InnoGen Pharmaceuticals Suraputide Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Guangzhou InnoGen Pharmaceuticals Main Business Overview
13.1.5 Guangzhou InnoGen Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Suraputide Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Suraputide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1 mg (0.5 mL) / pen
Table 4. Major Players of 3 mg (0.5 mL) / pen
Table 5. Global Suraputide Sales by Type (2021-2026) & (Units)
Table 6. Global Suraputide Sales Market Share by Type (2021-2026)
Table 7. Global Suraputide Revenue by Type (2021-2026) & ($ million)
Table 8. Global Suraputide Revenue Market Share by Type (2021-2026)
Table 9. Global Suraputide Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Combination of Supaglutide and Metformin
Table 11. Major Players of Combination of Supaglutide and DPP-4 inhibitors
Table 12. Global Suraputide Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global Suraputide Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global Suraputide Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global Suraputide Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global Suraputide Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Suraputide Sales by Sales Channel (2021-2026) & (Units)
Table 21. Global Suraputide Sales Market Share by Sales Channel (2021-2026)
Table 22. Global Suraputide Revenue by Sales Channel (2021-2026) & ($ million)
Table 23. Global Suraputide Revenue Market Share by Sales Channel (2021-2026)
Table 24. Global Suraputide Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 25. Global Suraputide Sale by Application (2021-2026) & (Units)
Table 26. Global Suraputide Sale Market Share by Application (2021-2026)
Table 27. Global Suraputide Revenue by Application (2021-2026) & ($ million)
Table 28. Global Suraputide Revenue Market Share by Application (2021-2026)
Table 29. Global Suraputide Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Suraputide Sales by Company (2021-2026) & (Units)
Table 31. Global Suraputide Sales Market Share by Company (2021-2026)
Table 32. Global Suraputide Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Suraputide Revenue Market Share by Company (2021-2026)
Table 34. Global Suraputide Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Suraputide Producing Area Distribution and Sales Area
Table 36. Players Suraputide Products Offered
Table 37. Suraputide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Suraputide Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Suraputide Sales Market Share Geographic Region (2021-2026)
Table 42. Global Suraputide Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Suraputide Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Suraputide Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Suraputide Sales Market Share by Country/Region (2021-2026)
Table 46. Global Suraputide Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Suraputide Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Suraputide Sales by Country (2021-2026) & (Units)
Table 49. Americas Suraputide Sales Market Share by Country (2021-2026)
Table 50. Americas Suraputide Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Suraputide Sales by Type (2021-2026) & (Units)
Table 52. Americas Suraputide Sales by Application (2021-2026) & (Units)
Table 53. APAC Suraputide Sales by Region (2021-2026) & (Units)
Table 54. APAC Suraputide Sales Market Share by Region (2021-2026)
Table 55. APAC Suraputide Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Suraputide Sales by Type (2021-2026) & (Units)
Table 57. APAC Suraputide Sales by Application (2021-2026) & (Units)
Table 58. Europe Suraputide Sales by Country (2021-2026) & (Units)
Table 59. Europe Suraputide Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Suraputide Sales by Type (2021-2026) & (Units)
Table 61. Europe Suraputide Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Suraputide Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Suraputide Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Suraputide Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Suraputide Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Suraputide
Table 67. Key Market Challenges & Risks of Suraputide
Table 68. Key Industry Trends of Suraputide
Table 69. Suraputide Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Suraputide Distributors List
Table 72. Suraputide Customer List
Table 73. Global Suraputide Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Suraputide Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Suraputide Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Suraputide Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Suraputide Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Suraputide Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Suraputide Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Suraputide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Suraputide Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Suraputide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Suraputide Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Suraputide Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Suraputide Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Suraputide Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Guangzhou InnoGen Pharmaceuticals Basic Information, Suraputide Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangzhou InnoGen Pharmaceuticals Suraputide Product Portfolios and Specifications
Table 89. Guangzhou InnoGen Pharmaceuticals Suraputide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Guangzhou InnoGen Pharmaceuticals Main Business
Table 91. Guangzhou InnoGen Pharmaceuticals Latest Developments
Table 1. Suraputide Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Suraputide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1 mg (0.5 mL) / pen
Table 4. Major Players of 3 mg (0.5 mL) / pen
Table 5. Global Suraputide Sales by Type (2021-2026) & (Units)
Table 6. Global Suraputide Sales Market Share by Type (2021-2026)
Table 7. Global Suraputide Revenue by Type (2021-2026) & ($ million)
Table 8. Global Suraputide Revenue Market Share by Type (2021-2026)
Table 9. Global Suraputide Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Combination of Supaglutide and Metformin
Table 11. Major Players of Combination of Supaglutide and DPP-4 inhibitors
Table 12. Global Suraputide Sales by Combination Therapy (2021-2026) & (Units)
Table 13. Global Suraputide Sales Market Share by Combination Therapy (2021-2026)
Table 14. Global Suraputide Revenue by Combination Therapy (2021-2026) & ($ million)
Table 15. Global Suraputide Revenue Market Share by Combination Therapy (2021-2026)
Table 16. Global Suraputide Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Suraputide Sales by Sales Channel (2021-2026) & (Units)
Table 21. Global Suraputide Sales Market Share by Sales Channel (2021-2026)
Table 22. Global Suraputide Revenue by Sales Channel (2021-2026) & ($ million)
Table 23. Global Suraputide Revenue Market Share by Sales Channel (2021-2026)
Table 24. Global Suraputide Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 25. Global Suraputide Sale by Application (2021-2026) & (Units)
Table 26. Global Suraputide Sale Market Share by Application (2021-2026)
Table 27. Global Suraputide Revenue by Application (2021-2026) & ($ million)
Table 28. Global Suraputide Revenue Market Share by Application (2021-2026)
Table 29. Global Suraputide Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Suraputide Sales by Company (2021-2026) & (Units)
Table 31. Global Suraputide Sales Market Share by Company (2021-2026)
Table 32. Global Suraputide Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Suraputide Revenue Market Share by Company (2021-2026)
Table 34. Global Suraputide Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Suraputide Producing Area Distribution and Sales Area
Table 36. Players Suraputide Products Offered
Table 37. Suraputide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Suraputide Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Suraputide Sales Market Share Geographic Region (2021-2026)
Table 42. Global Suraputide Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Suraputide Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Suraputide Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Suraputide Sales Market Share by Country/Region (2021-2026)
Table 46. Global Suraputide Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Suraputide Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Suraputide Sales by Country (2021-2026) & (Units)
Table 49. Americas Suraputide Sales Market Share by Country (2021-2026)
Table 50. Americas Suraputide Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Suraputide Sales by Type (2021-2026) & (Units)
Table 52. Americas Suraputide Sales by Application (2021-2026) & (Units)
Table 53. APAC Suraputide Sales by Region (2021-2026) & (Units)
Table 54. APAC Suraputide Sales Market Share by Region (2021-2026)
Table 55. APAC Suraputide Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Suraputide Sales by Type (2021-2026) & (Units)
Table 57. APAC Suraputide Sales by Application (2021-2026) & (Units)
Table 58. Europe Suraputide Sales by Country (2021-2026) & (Units)
Table 59. Europe Suraputide Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Suraputide Sales by Type (2021-2026) & (Units)
Table 61. Europe Suraputide Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Suraputide Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Suraputide Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Suraputide Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Suraputide Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Suraputide
Table 67. Key Market Challenges & Risks of Suraputide
Table 68. Key Industry Trends of Suraputide
Table 69. Suraputide Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Suraputide Distributors List
Table 72. Suraputide Customer List
Table 73. Global Suraputide Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Suraputide Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Suraputide Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Suraputide Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Suraputide Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Suraputide Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Suraputide Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Suraputide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Suraputide Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Suraputide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Suraputide Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Suraputide Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Suraputide Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Suraputide Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Guangzhou InnoGen Pharmaceuticals Basic Information, Suraputide Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangzhou InnoGen Pharmaceuticals Suraputide Product Portfolios and Specifications
Table 89. Guangzhou InnoGen Pharmaceuticals Suraputide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Guangzhou InnoGen Pharmaceuticals Main Business
Table 91. Guangzhou InnoGen Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Suraputide
Figure 2. Suraputide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Suraputide Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Suraputide Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Suraputide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Suraputide Sales Market Share by Country/Region (2025)
Figure 10. Suraputide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1 mg (0.5 mL) / pen
Figure 12. Product Picture of 3 mg (0.5 mL) / pen
Figure 13. Global Suraputide Sales Market Share by Type in 2026
Figure 14. Global Suraputide Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Combination of Supaglutide and Metformin
Figure 16. Product Picture of Combination of Supaglutide and DPP-4 inhibitors
Figure 17. Global Suraputide Sales Market Share by Combination Therapy in 2026
Figure 18. Global Suraputide Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Suraputide Sales Market Share by Sales Channel in 2026
Figure 23. Global Suraputide Revenue Market Share by Sales Channel (2021-2026)
Figure 24. Suraputide Consumed in Type 2 Diabetes Mellitus
Figure 25. Global Suraputide Market: Type 2 Diabetes Mellitus (2021-2026) & (Units)
Figure 26. Suraputide Consumed in Obesity
Figure 27. Global Suraputide Market: Obesity (2021-2026) & (Units)
Figure 28. Suraputide Consumed in Metabolic Syndrome
Figure 29. Global Suraputide Market: Metabolic Syndrome (2021-2026) & (Units)
Figure 30. Suraputide Consumed in Others
Figure 31. Global Suraputide Market: Others (2021-2026) & (Units)
Figure 32. Global Suraputide Sale Market Share by Application (2025)
Figure 33. Global Suraputide Revenue Market Share by Application in 2025
Figure 34. Suraputide Sales by Company in 2025 (Units)
Figure 35. Global Suraputide Sales Market Share by Company in 2025
Figure 36. Suraputide Revenue by Company in 2025 ($ millions)
Figure 37. Global Suraputide Revenue Market Share by Company in 2025
Figure 38. Global Suraputide Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Suraputide Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Suraputide Sales 2021-2026 (Units)
Figure 41. Americas Suraputide Revenue 2021-2026 ($ millions)
Figure 42. APAC Suraputide Sales 2021-2026 (Units)
Figure 43. APAC Suraputide Revenue 2021-2026 ($ millions)
Figure 44. Europe Suraputide Sales 2021-2026 (Units)
Figure 45. Europe Suraputide Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Suraputide Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Suraputide Revenue 2021-2026 ($ millions)
Figure 48. Americas Suraputide Sales Market Share by Country in 2025
Figure 49. Americas Suraputide Revenue Market Share by Country (2021-2026)
Figure 50. Americas Suraputide Sales Market Share by Type (2021-2026)
Figure 51. Americas Suraputide Sales Market Share by Application (2021-2026)
Figure 52. United States Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Suraputide Sales Market Share by Region in 2025
Figure 57. APAC Suraputide Revenue Market Share by Region (2021-2026)
Figure 58. APAC Suraputide Sales Market Share by Type (2021-2026)
Figure 59. APAC Suraputide Sales Market Share by Application (2021-2026)
Figure 60. China Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 64. India Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Suraputide Sales Market Share by Country in 2025
Figure 68. Europe Suraputide Revenue Market Share by Country (2021-2026)
Figure 69. Europe Suraputide Sales Market Share by Type (2021-2026)
Figure 70. Europe Suraputide Sales Market Share by Application (2021-2026)
Figure 71. Germany Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 72. France Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Suraputide Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Suraputide Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Suraputide Sales Market Share by Application (2021-2026)
Figure 79. Egypt Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Suraputide in 2026
Figure 85. Manufacturing Process Analysis of Suraputide
Figure 86. Industry Chain Structure of Suraputide
Figure 87. Channels of Distribution
Figure 88. Global Suraputide Sales Market Forecast by Region (2027-2032)
Figure 89. Global Suraputide Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Suraputide Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Suraputide Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Suraputide Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Suraputide Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Suraputide
Figure 2. Suraputide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Suraputide Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Suraputide Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Suraputide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Suraputide Sales Market Share by Country/Region (2025)
Figure 10. Suraputide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1 mg (0.5 mL) / pen
Figure 12. Product Picture of 3 mg (0.5 mL) / pen
Figure 13. Global Suraputide Sales Market Share by Type in 2026
Figure 14. Global Suraputide Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Combination of Supaglutide and Metformin
Figure 16. Product Picture of Combination of Supaglutide and DPP-4 inhibitors
Figure 17. Global Suraputide Sales Market Share by Combination Therapy in 2026
Figure 18. Global Suraputide Revenue Market Share by Combination Therapy (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Suraputide Sales Market Share by Sales Channel in 2026
Figure 23. Global Suraputide Revenue Market Share by Sales Channel (2021-2026)
Figure 24. Suraputide Consumed in Type 2 Diabetes Mellitus
Figure 25. Global Suraputide Market: Type 2 Diabetes Mellitus (2021-2026) & (Units)
Figure 26. Suraputide Consumed in Obesity
Figure 27. Global Suraputide Market: Obesity (2021-2026) & (Units)
Figure 28. Suraputide Consumed in Metabolic Syndrome
Figure 29. Global Suraputide Market: Metabolic Syndrome (2021-2026) & (Units)
Figure 30. Suraputide Consumed in Others
Figure 31. Global Suraputide Market: Others (2021-2026) & (Units)
Figure 32. Global Suraputide Sale Market Share by Application (2025)
Figure 33. Global Suraputide Revenue Market Share by Application in 2025
Figure 34. Suraputide Sales by Company in 2025 (Units)
Figure 35. Global Suraputide Sales Market Share by Company in 2025
Figure 36. Suraputide Revenue by Company in 2025 ($ millions)
Figure 37. Global Suraputide Revenue Market Share by Company in 2025
Figure 38. Global Suraputide Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Suraputide Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Suraputide Sales 2021-2026 (Units)
Figure 41. Americas Suraputide Revenue 2021-2026 ($ millions)
Figure 42. APAC Suraputide Sales 2021-2026 (Units)
Figure 43. APAC Suraputide Revenue 2021-2026 ($ millions)
Figure 44. Europe Suraputide Sales 2021-2026 (Units)
Figure 45. Europe Suraputide Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Suraputide Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Suraputide Revenue 2021-2026 ($ millions)
Figure 48. Americas Suraputide Sales Market Share by Country in 2025
Figure 49. Americas Suraputide Revenue Market Share by Country (2021-2026)
Figure 50. Americas Suraputide Sales Market Share by Type (2021-2026)
Figure 51. Americas Suraputide Sales Market Share by Application (2021-2026)
Figure 52. United States Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Suraputide Sales Market Share by Region in 2025
Figure 57. APAC Suraputide Revenue Market Share by Region (2021-2026)
Figure 58. APAC Suraputide Sales Market Share by Type (2021-2026)
Figure 59. APAC Suraputide Sales Market Share by Application (2021-2026)
Figure 60. China Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 64. India Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Suraputide Sales Market Share by Country in 2025
Figure 68. Europe Suraputide Revenue Market Share by Country (2021-2026)
Figure 69. Europe Suraputide Sales Market Share by Type (2021-2026)
Figure 70. Europe Suraputide Sales Market Share by Application (2021-2026)
Figure 71. Germany Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 72. France Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Suraputide Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Suraputide Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Suraputide Sales Market Share by Application (2021-2026)
Figure 79. Egypt Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Suraputide Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Suraputide in 2026
Figure 85. Manufacturing Process Analysis of Suraputide
Figure 86. Industry Chain Structure of Suraputide
Figure 87. Channels of Distribution
Figure 88. Global Suraputide Sales Market Forecast by Region (2027-2032)
Figure 89. Global Suraputide Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Suraputide Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Suraputide Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Suraputide Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Suraputide Revenue Market Share Forecast by Application (2027-2032)
